Aantal gebruikers 2019-2023 voor ATC-subgroep C10AX : Overige antilipaemica
- Raming voor de totale Zvw-populatie
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| C10AX06 Omega-3-vetzuurpreparaat (Vazkepa ®) | . | . | . | . | 72 |
| C10AX09 Ezetimib (Ezetrol ®) | 159.500 | 175.130 | 193.950 | 215.550 | 242.670 |
| C10AX12 Lomitapide (Lojuxta ®) | 8 | 9 | 9 | 9 | 7 |
| C10AX13 Evolocumab (Repatha ®) | 9.727 | 11.572 | 13.299 | 15.602 | 17.868 |
| C10AX14 Alirocumab (Praluent ®) | 7.056 | 8.877 | 10.723 | 12.700 | 14.963 |
| C10AX15 Bempedoinezuur (Nilemdo ®) | . | . | . | . | 924 |
| C10AX16 Inclisiran (Leqvio ®) | . | . | . | 794 | 1.574 |